Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recent Onset Atrial Fibrillation”

19 trials

Showing 19 of 19 results

Large-scale testing (Phase 3)UnknownNCT01817439
What this trial is testing

Safety and Efficacy of Oral Versus Intravenous Amiodarone in the Treatment of AF

Who this might be right for
Atrial Fibrillation
Western Galilee Hospital-Nahariya 104
Large-scale testing (Phase 3)Study completedNCT00126061
What this trial is testing

Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects

Who this might be right for
Atrial FibrillationAtrial Flutter
Solvay Pharmaceuticals
Not applicableUnknownNCT02321085
What this trial is testing

The Comparison With Clinical Impacts on Functional Capacity and Symptom Improvement According to the Rhythm Control in Patients With Heart Failure and Recent Onset Atrial Fibrillation

Who this might be right for
Heart FailureRecent Onset Atrial Fibrillation
Yonsei University 150
Large-scale testing (Phase 3)Study completedNCT00668759
What this trial is testing

A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Advanz Pharma 254
Testing effectiveness (Phase 2)Active Not RecruitingNCT04680026
What this trial is testing

IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF)

Who this might be right for
Atrial Fibrillation
HUYABIO International, LLC. 150
Post-approval studies (Phase 4)Study completedNCT02389218
What this trial is testing

A Prospective Study of Medical Therapy Against Cryoballoon Ablation in Symptomatic Recent Onset Persistent AF

Who this might be right for
Atrial Fibrillation
University Hospital, Ghent 13
Post-approval studies (Phase 4)WithdrawnNCT01627106
What this trial is testing

A Study Comparing Vernakalant Therapy to Amiodarone Therapy in Acute Management of Recent Onset Atrial Fibrillation (AF) (MK-6621-055)

Who this might be right for
Atrial Fibrillation
Advanz Pharma
Testing effectiveness (Phase 2)Ended earlyNCT01259622
What this trial is testing

Effects of Intravenous K201 on the Restoration of Sinus Rhythm in Subjects With Symptomatic Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Sequel Pharmaceuticals, Inc 80
Post-approval studies (Phase 4)Study completedNCT01447862
What this trial is testing

Vernakalant Versus Ibutilide In Recent-Onset Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Medical University of Vienna 101
Large-scale testing (Phase 3)Study completedNCT00126022
What this trial is testing

Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects

Who this might be right for
Atrial FibrillationAtrial Flutter
Solvay Pharmaceuticals
Large-scale testing (Phase 3)Ended earlyNCT00989001
What this trial is testing

A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF)(MK-6621-045)

Who this might be right for
Atrial Fibrillation
Advanz Pharma 217
Not applicableLooking for participantsNCT04612335
What this trial is testing

Device-based Rate Versus Rhythm Control in Symptomatic Recent-onset Atrial Fibrillation (RACE 9 OBSERVE-AF)

Who this might be right for
Atrial Fibrillation
Maastricht University Medical Center 490
Large-scale testing (Phase 3)Ended earlyNCT05039359
What this trial is testing

Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation

Who this might be right for
Paroxysmal Atrial Fibrillation
InCarda Therapeutics, Inc. 54
Not applicableStudy completedNCT02955004
What this trial is testing

Electrical Cardioversion of Recent Onset Atrial Fibrillation - Silent Thromboembolic Events, Reverse Atrial Remodeling

Who this might be right for
Intracranial Embolism
Uppsala University Hospital 43
Not applicableStudy completedNCT01891058
What this trial is testing

Trial of Electrical Versus Pharmacological Cardioversion for RAFF in the ED

Who this might be right for
Atrial FibrillationAtrial Flutter
Ottawa Hospital Research Institute 396
Testing effectiveness (Phase 2)Study completedNCT03539302
What this trial is testing

INhalation of Flecainide to Convert Recent Onset SympTomatic Atrial Fibrillation to siNus rhyThm (INSTANT)

Who this might be right for
Paroxysmal Atrial Fibrillation (PAF)
InCarda Therapeutics, Inc. 176
Testing effectiveness (Phase 2)Study completedNCT01691313
What this trial is testing

Safety and Efficacy of Vanoxerine for Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm

Who this might be right for
Symptomatic Atrial FibrillationAtrial Flutter
Laguna Pharmaceuticals, Inc. 104
Large-scale testing (Phase 3)Study completedNCT00126074
What this trial is testing

Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects

Who this might be right for
Atrial FibrillationAtrial Flutter
Solvay Pharmaceuticals
Large-scale testing (Phase 3)Ended earlyNCT02454283
What this trial is testing

Safety and Efficacy of Vanoxerine for the Conversion of Subjects With Recent Onset Atrial Fibrillation or Flutter to Normal Sinus Rhythm

Who this might be right for
Atrial Fibrillation or Flutter
Laguna Pharmaceuticals, Inc. 41

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation